TY - JOUR
T1 - GABAB Agonists for the Treatment of Alcohol Use Disorder
AU - Gasbarrini, Antonio
AU - Addolorato, Giovanni
AU - Mirijello, Antonio
AU - Caputo, Francesco Maria
AU - Vassallo, Gabriele Angelo
AU - Caputo, Fabio
AU - Rolland, Benjamin
PY - 2015
Y1 - 2015
N2 - Almost 10% of the world's population is affected by alcohol use disorder (AUD). The combination between psychosocial intervention and pharmacological treatment seems to be the most effective approach for patients affected by AUD. Among effective drugs useful in the treatment of AUD, GABAB-ergic medications have been tested with encouraging results (i.e. sodium oxybate, baclofen, gabapentin, pregabalin and tiagabine). The present review will summarize available data on these medications.
AB - Almost 10% of the world's population is affected by alcohol use disorder (AUD). The combination between psychosocial intervention and pharmacological treatment seems to be the most effective approach for patients affected by AUD. Among effective drugs useful in the treatment of AUD, GABAB-ergic medications have been tested with encouraging results (i.e. sodium oxybate, baclofen, gabapentin, pregabalin and tiagabine). The present review will summarize available data on these medications.
KW - alcohol use disorder
KW - gabab
KW - alcohol use disorder
KW - gabab
UR - http://hdl.handle.net/10807/68223
M3 - Article
VL - 21
SP - 3367
EP - 3372
JO - CURRENT PHARMACEUTICAL DESIGN
JF - CURRENT PHARMACEUTICAL DESIGN
SN - 1873-4286
ER -